Appleyard Lees Fleck Barbara competitive analysis

Latest publications and patents of Appleyard Lees Fleck Barbara New

Explore the latest publications and patents granted to Appleyard Lees Fleck Barbara, showcasing their recent innovations and technological advancements.

Explore patent oppositions filed by Appleyard Lees Fleck Barbara against competitors, revealing strategic technology disputes and market positioning.

Last updated on: Sep 25, 2025
Patent NumberTitleApplicantOpposition Date

Get instant updates on new opposition filings by the company

Method Of Treating Cancer Using Immune Checkpoint InhibitorBRISTOL MYERS SQUIBBOct 13, 2021
Complexes Of Cytomegalovirus ProteinsGLAXOSMITHKLINEMay 7, 2020

Latest PTAB cases involving Appleyard Lees Fleck Barbara

Discover the latest PTAB cases involving Appleyard Lees Fleck Barbara, highlighting their recent legal challenges and patent disputes.

Peer Comparison New

IP litigation analysis comparing Appleyard Lees Fleck Barbara with top 3 competitors. Includes complete PTAB case data and opposition data from 2018 onwards.

Last updated on: Sep 25, 2025
CompanyOppositions FiledOppositions FacedPTAB Cases FiledPTAB Cases FacedStrategy Type
APPLEYARD LEES FLECK BARBARA2 - - - Highly Aggressive
BRISTOL MYERS SQUIBB - 66 - 8Non-Active
GLAXOSMITHKLINE29112812Defensive
NOVARTIS6406 - 21Defensive